Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cytidine Deaminase | 12 | 2024 | 252 | 2.450 |
Why?
|
Mutation | 74 | 2024 | 29786 | 1.170 |
Why?
|
Retinoblastoma Protein | 5 | 2023 | 704 | 1.130 |
Why?
|
Genomics | 21 | 2019 | 5720 | 1.100 |
Why?
|
Chromatin | 9 | 2023 | 2934 | 1.090 |
Why?
|
Genome, Human | 27 | 2020 | 4420 | 1.080 |
Why?
|
Software | 13 | 2019 | 4443 | 1.040 |
Why?
|
Neoplasms | 40 | 2024 | 21683 | 0.990 |
Why?
|
Minor Histocompatibility Antigens | 4 | 2024 | 298 | 0.960 |
Why?
|
Databases, Genetic | 15 | 2020 | 1783 | 0.960 |
Why?
|
Cell Transformation, Neoplastic | 7 | 2021 | 2942 | 0.880 |
Why?
|
Proteins | 8 | 2024 | 6103 | 0.860 |
Why?
|
Rumen | 1 | 2021 | 17 | 0.790 |
Why?
|
High-Throughput Nucleotide Sequencing | 18 | 2023 | 3597 | 0.740 |
Why?
|
Nucleic Acid Conformation | 5 | 2021 | 913 | 0.730 |
Why?
|
Genes, Neoplasm | 4 | 2017 | 376 | 0.670 |
Why?
|
Sequence Analysis, DNA | 23 | 2019 | 4803 | 0.640 |
Why?
|
Cytosine | 5 | 2024 | 216 | 0.570 |
Why?
|
Computational Biology | 16 | 2020 | 3521 | 0.560 |
Why?
|
Mutagenesis | 9 | 2021 | 1266 | 0.560 |
Why?
|
Gene Expression Regulation, Neoplastic | 22 | 2021 | 8428 | 0.550 |
Why?
|
RNA, Catalytic | 3 | 2005 | 50 | 0.540 |
Why?
|
DNA | 9 | 2024 | 7301 | 0.520 |
Why?
|
Drug Resistance, Neoplasm | 13 | 2023 | 5172 | 0.510 |
Why?
|
Genetic Heterogeneity | 4 | 2015 | 733 | 0.490 |
Why?
|
Oncogenes | 4 | 2016 | 1265 | 0.420 |
Why?
|
Lung Neoplasms | 16 | 2023 | 13102 | 0.420 |
Why?
|
Genome | 5 | 2023 | 1808 | 0.410 |
Why?
|
RNA Splicing | 6 | 2020 | 907 | 0.380 |
Why?
|
DNA Mutational Analysis | 14 | 2020 | 4186 | 0.380 |
Why?
|
Cell Line, Tumor | 22 | 2022 | 16689 | 0.360 |
Why?
|
DNA, Neoplasm | 6 | 2015 | 1758 | 0.350 |
Why?
|
E2F Transcription Factors | 4 | 2023 | 277 | 0.340 |
Why?
|
Adenocarcinoma | 12 | 2016 | 6364 | 0.330 |
Why?
|
RNA Editing | 3 | 2020 | 148 | 0.320 |
Why?
|
Sequence Alignment | 6 | 2016 | 2256 | 0.320 |
Why?
|
DNA Copy Number Variations | 9 | 2020 | 1941 | 0.320 |
Why?
|
HEK293 Cells | 8 | 2021 | 4204 | 0.310 |
Why?
|
Mitogen-Activated Protein Kinase 1 | 3 | 2013 | 489 | 0.310 |
Why?
|
DNA Mismatch Repair | 2 | 2023 | 426 | 0.310 |
Why?
|
Mitogen-Activated Protein Kinase 3 | 2 | 2008 | 480 | 0.290 |
Why?
|
RNA | 6 | 2023 | 2749 | 0.280 |
Why?
|
Neoplastic Cells, Circulating | 4 | 2023 | 934 | 0.280 |
Why?
|
Small Cell Lung Carcinoma | 2 | 2022 | 388 | 0.270 |
Why?
|
BRCA2 Protein | 3 | 2020 | 794 | 0.270 |
Why?
|
DNA-Directed RNA Polymerases | 2 | 2005 | 371 | 0.270 |
Why?
|
RNA Ligase (ATP) | 1 | 2005 | 9 | 0.270 |
Why?
|
G-Quadruplexes | 2 | 2019 | 162 | 0.270 |
Why?
|
Uracil | 3 | 2024 | 165 | 0.260 |
Why?
|
Lactams | 3 | 2021 | 156 | 0.260 |
Why?
|
Humans | 142 | 2024 | 744343 | 0.260 |
Why?
|
RNA Processing, Post-Transcriptional | 3 | 2020 | 436 | 0.260 |
Why?
|
DNA Methylation | 6 | 2023 | 4286 | 0.260 |
Why?
|
Papillomavirus Infections | 5 | 2021 | 1587 | 0.250 |
Why?
|
Human papillomavirus 16 | 3 | 2021 | 262 | 0.240 |
Why?
|
Immune Evasion | 2 | 2020 | 360 | 0.230 |
Why?
|
Cell Cycle Proteins | 5 | 2022 | 3462 | 0.230 |
Why?
|
DNA Replication | 6 | 2024 | 1399 | 0.220 |
Why?
|
Base Sequence | 10 | 2021 | 12797 | 0.220 |
Why?
|
Insulin-Secreting Cells | 2 | 2008 | 891 | 0.220 |
Why?
|
Oncogene Proteins | 3 | 2015 | 749 | 0.210 |
Why?
|
Aminopyridines | 3 | 2021 | 542 | 0.210 |
Why?
|
E1A-Associated p300 Protein | 2 | 2021 | 131 | 0.210 |
Why?
|
E2F1 Transcription Factor | 1 | 2022 | 190 | 0.210 |
Why?
|
Histones | 5 | 2019 | 2599 | 0.210 |
Why?
|
Neoplasms, Squamous Cell | 2 | 2013 | 96 | 0.210 |
Why?
|
Gene Regulatory Networks | 5 | 2017 | 1708 | 0.200 |
Why?
|
Gene Amplification | 4 | 2020 | 1063 | 0.200 |
Why?
|
Green Fluorescent Proteins | 1 | 2007 | 2088 | 0.200 |
Why?
|
Nuclear Receptor Subfamily 4, Group A, Member 1 | 1 | 2021 | 70 | 0.200 |
Why?
|
Head and Neck Neoplasms | 4 | 2022 | 2734 | 0.200 |
Why?
|
Guanosine Triphosphate | 2 | 2019 | 321 | 0.200 |
Why?
|
Digestion | 1 | 2021 | 54 | 0.200 |
Why?
|
Point Mutation | 4 | 2015 | 1623 | 0.190 |
Why?
|
Promoter Regions, Genetic | 4 | 2022 | 5867 | 0.190 |
Why?
|
Animal Feed | 1 | 2021 | 110 | 0.190 |
Why?
|
Transcription Factor AP-1 | 1 | 2022 | 317 | 0.190 |
Why?
|
Oncogene Proteins, Fusion | 3 | 2021 | 1581 | 0.190 |
Why?
|
DNA Repair | 5 | 2023 | 2046 | 0.190 |
Why?
|
Fermentation | 1 | 2021 | 144 | 0.190 |
Why?
|
CREB-Binding Protein | 1 | 2021 | 151 | 0.190 |
Why?
|
Genome, Viral | 2 | 2021 | 667 | 0.180 |
Why?
|
Gene Expression Profiling | 10 | 2021 | 9438 | 0.180 |
Why?
|
Protein Kinase Inhibitors | 8 | 2022 | 5535 | 0.180 |
Why?
|
Tristetraprolin | 1 | 2020 | 42 | 0.180 |
Why?
|
Gene Rearrangement | 5 | 2018 | 1179 | 0.180 |
Why?
|
Sample Size | 2 | 2014 | 845 | 0.180 |
Why?
|
Lactobacillus | 1 | 2021 | 189 | 0.180 |
Why?
|
INDEL Mutation | 2 | 2020 | 279 | 0.180 |
Why?
|
Microsatellite Repeats | 3 | 2017 | 802 | 0.180 |
Why?
|
Lactams, Macrocyclic | 2 | 2020 | 320 | 0.180 |
Why?
|
Carcinoma, Squamous Cell | 6 | 2016 | 4034 | 0.180 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2023 | 893 | 0.180 |
Why?
|
Breast Neoplasms | 8 | 2021 | 20822 | 0.170 |
Why?
|
Genes, Tumor Suppressor | 4 | 2019 | 1097 | 0.170 |
Why?
|
Escherichia coli | 4 | 2022 | 4217 | 0.170 |
Why?
|
Genomic Instability | 3 | 2023 | 695 | 0.170 |
Why?
|
Retinoblastoma-Binding Protein 2 | 1 | 2018 | 31 | 0.160 |
Why?
|
Immediate-Early Proteins | 1 | 2021 | 453 | 0.160 |
Why?
|
Cerebellar Neoplasms | 2 | 2014 | 587 | 0.160 |
Why?
|
Lactation | 1 | 2021 | 412 | 0.160 |
Why?
|
Mitogen-Activated Protein Kinase Kinases | 1 | 2021 | 648 | 0.160 |
Why?
|
beta-Galactosidase | 1 | 1999 | 573 | 0.160 |
Why?
|
Leukemia, Lymphocytic, Chronic, B-Cell | 3 | 2015 | 1596 | 0.160 |
Why?
|
Exons | 6 | 2016 | 2437 | 0.160 |
Why?
|
DNA Polymerase III | 1 | 2018 | 55 | 0.160 |
Why?
|
Subcutaneous Fat, Abdominal | 1 | 2018 | 93 | 0.160 |
Why?
|
Milk | 1 | 2021 | 450 | 0.160 |
Why?
|
Haploinsufficiency | 1 | 2020 | 328 | 0.160 |
Why?
|
Endometrial Neoplasms | 3 | 2018 | 1353 | 0.160 |
Why?
|
Caudate Nucleus | 1 | 1999 | 393 | 0.160 |
Why?
|
GTPase-Activating Proteins | 1 | 2021 | 498 | 0.150 |
Why?
|
Extracellular Matrix Proteins | 1 | 2022 | 849 | 0.150 |
Why?
|
DNA Polymerase II | 1 | 2018 | 107 | 0.150 |
Why?
|
Sequence Analysis, RNA | 4 | 2016 | 2012 | 0.150 |
Why?
|
Models, Molecular | 8 | 2021 | 5456 | 0.150 |
Why?
|
Prostatic Neoplasms | 5 | 2023 | 11124 | 0.150 |
Why?
|
Proto-Oncogene Proteins | 4 | 2021 | 4554 | 0.150 |
Why?
|
Algorithms | 12 | 2018 | 13881 | 0.150 |
Why?
|
DNA Replication Timing | 2 | 2015 | 35 | 0.150 |
Why?
|
Lysine | 2 | 2019 | 1007 | 0.150 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 4 | 2020 | 5221 | 0.150 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 11 | 1 | 2018 | 234 | 0.150 |
Why?
|
Orthodontic Brackets | 1 | 2017 | 28 | 0.150 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2021 | 604 | 0.140 |
Why?
|
Animals | 29 | 2023 | 168757 | 0.140 |
Why?
|
Proteomics | 4 | 2023 | 3638 | 0.140 |
Why?
|
Lymphoma, Large B-Cell, Diffuse | 2 | 2020 | 1378 | 0.140 |
Why?
|
Cell Proliferation | 5 | 2021 | 10481 | 0.140 |
Why?
|
Anesthesia, Epidural | 1 | 2018 | 228 | 0.140 |
Why?
|
Genes, X-Linked | 1 | 2016 | 128 | 0.140 |
Why?
|
Parkinson Disease | 2 | 2023 | 2775 | 0.140 |
Why?
|
Mitosis | 1 | 2021 | 1208 | 0.140 |
Why?
|
Cell Nucleus | 2 | 2023 | 2969 | 0.140 |
Why?
|
Hepatocyte Nuclear Factor 3-alpha | 2 | 2017 | 170 | 0.140 |
Why?
|
Deoxyribonucleases | 1 | 2017 | 214 | 0.140 |
Why?
|
Orthotic Devices | 1 | 2017 | 128 | 0.140 |
Why?
|
Cattle | 2 | 2021 | 3922 | 0.130 |
Why?
|
Proto-Oncogene Proteins c-met | 1 | 2020 | 578 | 0.130 |
Why?
|
Gene Dosage | 5 | 2014 | 1252 | 0.130 |
Why?
|
Transgenes | 1 | 1999 | 1009 | 0.130 |
Why?
|
Papillomaviridae | 4 | 2015 | 1119 | 0.130 |
Why?
|
Pyrazoles | 3 | 2021 | 1972 | 0.130 |
Why?
|
Astrocytoma | 1 | 2020 | 790 | 0.130 |
Why?
|
Epilepsies, Myoclonic | 1 | 2016 | 80 | 0.130 |
Why?
|
Endometrial Hyperplasia | 1 | 2016 | 97 | 0.130 |
Why?
|
BRCA1 Protein | 2 | 2020 | 1149 | 0.130 |
Why?
|
Reactive Oxygen Species | 1 | 2023 | 2077 | 0.130 |
Why?
|
Signal Transduction | 14 | 2021 | 23403 | 0.130 |
Why?
|
Oropharyngeal Neoplasms | 1 | 2021 | 477 | 0.130 |
Why?
|
Molecular Sequence Annotation | 2 | 2017 | 528 | 0.130 |
Why?
|
Cytomegalovirus Infections | 1 | 2022 | 820 | 0.130 |
Why?
|
DNA Damage | 4 | 2022 | 2432 | 0.130 |
Why?
|
Mice | 19 | 2023 | 81183 | 0.130 |
Why?
|
Adenoviridae | 1 | 1999 | 1099 | 0.130 |
Why?
|
Chromosomes, Human, X | 1 | 2016 | 296 | 0.130 |
Why?
|
Small Molecule Libraries | 1 | 2021 | 720 | 0.130 |
Why?
|
Transforming Growth Factor beta | 1 | 2023 | 2007 | 0.130 |
Why?
|
Feces | 1 | 2021 | 1401 | 0.130 |
Why?
|
Alleles | 5 | 2021 | 6933 | 0.130 |
Why?
|
Nuclear Proteins | 3 | 2022 | 5853 | 0.120 |
Why?
|
X Chromosome Inactivation | 1 | 2016 | 224 | 0.120 |
Why?
|
Female | 49 | 2022 | 380194 | 0.120 |
Why?
|
Abdominal Neoplasms | 1 | 2016 | 292 | 0.120 |
Why?
|
Immunoconjugates | 1 | 2022 | 901 | 0.120 |
Why?
|
Gait Disorders, Neurologic | 1 | 2017 | 231 | 0.120 |
Why?
|
Hemangioblastoma | 1 | 2014 | 70 | 0.120 |
Why?
|
DNA, Bacterial | 1 | 2019 | 1465 | 0.120 |
Why?
|
Xeroderma Pigmentosum Group D Protein | 1 | 2014 | 105 | 0.120 |
Why?
|
Pelvic Neoplasms | 1 | 2016 | 254 | 0.120 |
Why?
|
Phosphatidylinositol 3-Kinases | 4 | 2022 | 2938 | 0.120 |
Why?
|
Esophageal Neoplasms | 2 | 2015 | 1583 | 0.120 |
Why?
|
Neoplasm Proteins | 5 | 2018 | 3703 | 0.120 |
Why?
|
Colorectal Neoplasms | 4 | 2015 | 6773 | 0.120 |
Why?
|
Transcription, Genetic | 9 | 2019 | 7722 | 0.120 |
Why?
|
Phthalazines | 3 | 2022 | 363 | 0.120 |
Why?
|
Gene Transfer Techniques | 1 | 1999 | 1224 | 0.120 |
Why?
|
Brain Neoplasms | 4 | 2020 | 8863 | 0.120 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2022 | 1366 | 0.120 |
Why?
|
Antigens, Nuclear | 1 | 2014 | 192 | 0.120 |
Why?
|
Tumor Microenvironment | 3 | 2023 | 3586 | 0.120 |
Why?
|
Immunization Programs | 1 | 1996 | 260 | 0.120 |
Why?
|
Organ Specificity | 2 | 2016 | 2008 | 0.120 |
Why?
|
Cloning, Molecular | 3 | 2012 | 4320 | 0.120 |
Why?
|
Adenosine Deaminase | 1 | 2016 | 241 | 0.120 |
Why?
|
Genetic Predisposition to Disease | 9 | 2020 | 17446 | 0.110 |
Why?
|
Molecular Sequence Data | 8 | 2016 | 18111 | 0.110 |
Why?
|
Von Hippel-Lindau Tumor Suppressor Protein | 1 | 2014 | 290 | 0.110 |
Why?
|
Movement Disorders | 1 | 2017 | 445 | 0.110 |
Why?
|
Epigenesis, Genetic | 5 | 2023 | 3647 | 0.110 |
Why?
|
Retroelements | 1 | 2014 | 164 | 0.110 |
Why?
|
Cell Line | 7 | 2022 | 15997 | 0.110 |
Why?
|
Models, Genetic | 3 | 2019 | 3494 | 0.110 |
Why?
|
Chromosome Mapping | 2 | 2019 | 4740 | 0.110 |
Why?
|
Killer Cells, Natural | 1 | 2022 | 2133 | 0.110 |
Why?
|
Genetic Variation | 4 | 2016 | 6544 | 0.110 |
Why?
|
Melanoma | 4 | 2018 | 5510 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4479 | 0.110 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 1 | 2013 | 323 | 0.110 |
Why?
|
Protein Isoforms | 2 | 2016 | 1730 | 0.110 |
Why?
|
Genes, p53 | 1 | 2015 | 755 | 0.110 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2015 | 730 | 0.110 |
Why?
|
High-Throughput Screening Assays | 2 | 2016 | 944 | 0.110 |
Why?
|
Genomic Library | 1 | 2012 | 193 | 0.110 |
Why?
|
Uterine Cervical Neoplasms | 3 | 2015 | 2020 | 0.100 |
Why?
|
Urothelium | 1 | 2014 | 277 | 0.100 |
Why?
|
Chromosome Breakage | 1 | 2012 | 173 | 0.100 |
Why?
|
Bone Neoplasms | 2 | 2014 | 2529 | 0.100 |
Why?
|
Spinal Cord Neoplasms | 1 | 2014 | 281 | 0.100 |
Why?
|
DNA-Binding Proteins | 6 | 2015 | 9648 | 0.100 |
Why?
|
Qb-SNARE Proteins | 1 | 2011 | 36 | 0.100 |
Why?
|
Mediator Complex | 1 | 2012 | 109 | 0.100 |
Why?
|
Evolution, Molecular | 2 | 2021 | 1940 | 0.100 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2021 | 2455 | 0.100 |
Why?
|
Anesthesia, Local | 1 | 1994 | 275 | 0.100 |
Why?
|
Receptors, Mitogen | 1 | 2011 | 62 | 0.100 |
Why?
|
Transcription Factors | 5 | 2022 | 12208 | 0.100 |
Why?
|
Cluster Analysis | 5 | 2018 | 2715 | 0.100 |
Why?
|
Terminology as Topic | 1 | 2019 | 1547 | 0.100 |
Why?
|
Tumor Virus Infections | 1 | 2014 | 452 | 0.100 |
Why?
|
Spliceosomes | 1 | 2011 | 110 | 0.100 |
Why?
|
Genome, Fungal | 1 | 2012 | 204 | 0.100 |
Why?
|
Carcinogens | 1 | 2013 | 466 | 0.100 |
Why?
|
Gene Expression | 5 | 2016 | 7799 | 0.100 |
Why?
|
Transcription Factor 7-Like 2 Protein | 1 | 2011 | 154 | 0.100 |
Why?
|
Ovarian Neoplasms | 2 | 2022 | 4838 | 0.100 |
Why?
|
Barrett Esophagus | 1 | 2015 | 494 | 0.100 |
Why?
|
Receptor, erbB-2 | 4 | 2014 | 2416 | 0.100 |
Why?
|
Mutation, Missense | 3 | 2015 | 2564 | 0.100 |
Why?
|
Ribonucleoproteins | 1 | 2014 | 381 | 0.100 |
Why?
|
Genome-Wide Association Study | 9 | 2020 | 12261 | 0.100 |
Why?
|
Intestinal Neoplasms | 1 | 2013 | 319 | 0.100 |
Why?
|
Craniopharyngioma | 1 | 2014 | 281 | 0.100 |
Why?
|
Food Labeling | 1 | 2013 | 178 | 0.100 |
Why?
|
Enzyme Inhibitors | 2 | 2021 | 3798 | 0.100 |
Why?
|
Cell Cycle | 4 | 2023 | 2967 | 0.090 |
Why?
|
Neurofibromatosis 1 | 2 | 2010 | 569 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2013 | 981 | 0.090 |
Why?
|
Neuroendocrine Tumors | 2 | 2013 | 594 | 0.090 |
Why?
|
Statistics as Topic | 1 | 2017 | 2373 | 0.090 |
Why?
|
Ultraviolet Rays | 2 | 2012 | 1060 | 0.090 |
Why?
|
Protein Binding | 5 | 2022 | 9386 | 0.090 |
Why?
|
Recombination, Genetic | 2 | 2012 | 1586 | 0.090 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2022 | 2109 | 0.090 |
Why?
|
Sunlight | 1 | 2012 | 325 | 0.090 |
Why?
|
Computer Graphics | 1 | 2012 | 361 | 0.090 |
Why?
|
Urologic Neoplasms | 1 | 2014 | 318 | 0.090 |
Why?
|
Rhabdoid Tumor | 1 | 2012 | 212 | 0.090 |
Why?
|
Schizosaccharomyces | 1 | 2012 | 237 | 0.090 |
Why?
|
RNA-Binding Proteins | 2 | 2017 | 1903 | 0.090 |
Why?
|
Regulatory Sequences, Nucleic Acid | 1 | 2013 | 794 | 0.090 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 3 | 2019 | 11524 | 0.090 |
Why?
|
Biological Specimen Banks | 1 | 2015 | 711 | 0.090 |
Why?
|
Chromatin Assembly and Disassembly | 3 | 2021 | 635 | 0.090 |
Why?
|
MyoD Protein | 1 | 2010 | 151 | 0.090 |
Why?
|
Stress, Physiological | 1 | 2017 | 1403 | 0.090 |
Why?
|
Translocation, Genetic | 2 | 2012 | 1420 | 0.090 |
Why?
|
Protein Structure, Tertiary | 5 | 2015 | 3846 | 0.090 |
Why?
|
Nutrition Policy | 1 | 2013 | 488 | 0.090 |
Why?
|
Chromosome Aberrations | 2 | 2013 | 1813 | 0.080 |
Why?
|
Glioma | 2 | 2015 | 3401 | 0.080 |
Why?
|
Organoids | 1 | 2015 | 701 | 0.080 |
Why?
|
Osteosarcoma | 1 | 2014 | 881 | 0.080 |
Why?
|
Influenza Vaccines | 1 | 1996 | 738 | 0.080 |
Why?
|
Microsatellite Instability | 3 | 2018 | 684 | 0.080 |
Why?
|
Proto-Oncogene Proteins B-raf | 3 | 2014 | 2043 | 0.080 |
Why?
|
Male | 38 | 2023 | 350118 | 0.080 |
Why?
|
DNA Breaks, Double-Stranded | 2 | 2023 | 594 | 0.080 |
Why?
|
Proteome | 2 | 2020 | 1799 | 0.080 |
Why?
|
Adenocarcinoma, Bronchiolo-Alveolar | 1 | 2008 | 91 | 0.080 |
Why?
|
Kinetics | 3 | 2007 | 6473 | 0.080 |
Why?
|
Receptor, Notch1 | 1 | 2011 | 502 | 0.080 |
Why?
|
Guanine Nucleotide Exchange Factors | 1 | 2012 | 581 | 0.080 |
Why?
|
Cisplatin | 1 | 2014 | 1662 | 0.080 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2019 | 1634 | 0.080 |
Why?
|
Chromosome Breakpoints | 3 | 2012 | 98 | 0.080 |
Why?
|
Transcription Factor CHOP | 1 | 2008 | 73 | 0.080 |
Why?
|
Beverages | 1 | 2013 | 820 | 0.080 |
Why?
|
Receptor, Platelet-Derived Growth Factor alpha | 1 | 2010 | 379 | 0.080 |
Why?
|
Polymorphism, Single Nucleotide | 6 | 2021 | 15519 | 0.080 |
Why?
|
Choice Behavior | 1 | 2013 | 803 | 0.080 |
Why?
|
Xenograft Model Antitumor Assays | 3 | 2021 | 3557 | 0.080 |
Why?
|
Spectrophotometry, Ultraviolet | 1 | 2007 | 220 | 0.080 |
Why?
|
Genetic Vectors | 2 | 2012 | 3420 | 0.080 |
Why?
|
Tumor Cells, Cultured | 3 | 2021 | 6314 | 0.080 |
Why?
|
Antineoplastic Agents | 5 | 2023 | 13695 | 0.070 |
Why?
|
Genome, Bacterial | 1 | 2012 | 760 | 0.070 |
Why?
|
alpha-Amylases | 1 | 2007 | 41 | 0.070 |
Why?
|
Histone-Lysine N-Methyltransferase | 3 | 2019 | 670 | 0.070 |
Why?
|
RNA, Bacterial | 1 | 2009 | 390 | 0.070 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2012 | 736 | 0.070 |
Why?
|
Health Promotion | 2 | 2023 | 2205 | 0.070 |
Why?
|
Protein Kinases | 1 | 2014 | 1640 | 0.070 |
Why?
|
Medulloblastoma | 1 | 2012 | 683 | 0.070 |
Why?
|
Static Electricity | 1 | 2007 | 267 | 0.070 |
Why?
|
User-Computer Interface | 2 | 2015 | 1431 | 0.070 |
Why?
|
Microtubule-Associated Proteins | 1 | 2012 | 1086 | 0.070 |
Why?
|
Tumor Suppressor Protein p53 | 5 | 2015 | 2948 | 0.070 |
Why?
|
NF-E2-Related Factor 2 | 3 | 2013 | 377 | 0.070 |
Why?
|
Middle Aged | 24 | 2021 | 213383 | 0.070 |
Why?
|
Piperazines | 3 | 2022 | 2488 | 0.070 |
Why?
|
Mice, Inbred NOD | 2 | 2021 | 1878 | 0.070 |
Why?
|
Apoptosis | 4 | 2014 | 9727 | 0.070 |
Why?
|
Reproducibility of Results | 5 | 2016 | 19905 | 0.070 |
Why?
|
Melanocytes | 3 | 2015 | 515 | 0.070 |
Why?
|
Aneuploidy | 2 | 2020 | 530 | 0.070 |
Why?
|
Preventive Medicine | 2 | 1985 | 264 | 0.070 |
Why?
|
Ultrasonography | 1 | 2018 | 5985 | 0.070 |
Why?
|
Germ-Line Mutation | 3 | 2020 | 1788 | 0.060 |
Why?
|
RNA, Untranslated | 1 | 2009 | 453 | 0.060 |
Why?
|
Influenza, Human | 1 | 1996 | 1479 | 0.060 |
Why?
|
Medical Audit | 2 | 1983 | 467 | 0.060 |
Why?
|
Spectrometry, Fluorescence | 1 | 2007 | 689 | 0.060 |
Why?
|
Pituitary Neoplasms | 1 | 2014 | 1345 | 0.060 |
Why?
|
Mice, SCID | 2 | 2021 | 2716 | 0.060 |
Why?
|
Neuroblastoma | 1 | 2013 | 1226 | 0.060 |
Why?
|
Intracellular Signaling Peptides and Proteins | 4 | 2020 | 2915 | 0.060 |
Why?
|
Amino Acid Sequence | 4 | 2012 | 13815 | 0.060 |
Why?
|
Stomach Neoplasms | 1 | 2014 | 1333 | 0.060 |
Why?
|
Multiple Myeloma | 2 | 2014 | 5181 | 0.060 |
Why?
|
Artifacts | 1 | 2013 | 1904 | 0.060 |
Why?
|
Surface Properties | 1 | 2007 | 1184 | 0.060 |
Why?
|
Isocitrate Dehydrogenase | 1 | 2010 | 871 | 0.060 |
Why?
|
Cohort Studies | 9 | 2018 | 40561 | 0.060 |
Why?
|
Aged | 20 | 2021 | 163280 | 0.060 |
Why?
|
Molecular Targeted Therapy | 3 | 2023 | 2727 | 0.060 |
Why?
|
Diacylglycerol Kinase | 1 | 2023 | 48 | 0.060 |
Why?
|
Mice, Nude | 3 | 2018 | 3689 | 0.060 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2011 | 1660 | 0.060 |
Why?
|
Core Binding Factor beta Subunit | 2 | 2013 | 45 | 0.060 |
Why?
|
Adult | 22 | 2021 | 214055 | 0.060 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2012 | 2016 | 0.060 |
Why?
|
Gene Expression Regulation | 3 | 2016 | 12072 | 0.060 |
Why?
|
Radiotherapy Planning, Computer-Assisted | 1 | 2012 | 1624 | 0.060 |
Why?
|
beta Catenin | 3 | 2014 | 1059 | 0.060 |
Why?
|
Trans-Activators | 1 | 2013 | 2924 | 0.060 |
Why?
|
Ploidies | 2 | 2013 | 281 | 0.060 |
Why?
|
Diet | 1 | 2021 | 7939 | 0.050 |
Why?
|
Vibrio cholerae | 1 | 2009 | 806 | 0.050 |
Why?
|
Peptides | 2 | 2022 | 4409 | 0.050 |
Why?
|
DNA, Single-Stranded | 1 | 2024 | 354 | 0.050 |
Why?
|
Somatic Hypermutation, Immunoglobulin | 1 | 2022 | 97 | 0.050 |
Why?
|
Radiopharmaceuticals | 1 | 2012 | 2645 | 0.050 |
Why?
|
Phenylacetates | 1 | 2021 | 114 | 0.050 |
Why?
|
DNA Topoisomerases, Type I | 1 | 2022 | 102 | 0.050 |
Why?
|
Catalysis | 1 | 2003 | 761 | 0.050 |
Why?
|
Phenotype | 4 | 2023 | 16365 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2008 | 3701 | 0.050 |
Why?
|
Pancreatic Neoplasms | 1 | 2019 | 5256 | 0.050 |
Why?
|
Calcium-Transporting ATPases | 1 | 2001 | 123 | 0.050 |
Why?
|
Case-Control Studies | 3 | 2014 | 21746 | 0.050 |
Why?
|
Survival Analysis | 1 | 2014 | 10252 | 0.050 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2013 | 2214 | 0.050 |
Why?
|
Insulin | 2 | 2008 | 6580 | 0.050 |
Why?
|
Ubiquitin-Protein Ligases | 3 | 2015 | 1861 | 0.050 |
Why?
|
Body Mass Index | 1 | 2018 | 12720 | 0.050 |
Why?
|
Genetic Association Studies | 3 | 2016 | 2703 | 0.050 |
Why?
|
CpG Islands | 2 | 2018 | 1172 | 0.050 |
Why?
|
Family Practice | 3 | 1992 | 516 | 0.050 |
Why?
|
Medical Records | 3 | 1985 | 1413 | 0.050 |
Why?
|
Dual Specificity Phosphatase 1 | 1 | 2020 | 44 | 0.050 |
Why?
|
Antigens, Differentiation, B-Lymphocyte | 1 | 2021 | 318 | 0.050 |
Why?
|
Immunoglobulin Class Switching | 1 | 2022 | 291 | 0.050 |
Why?
|
Models, Biological | 3 | 2012 | 9583 | 0.050 |
Why?
|
Class I Phosphatidylinositol 3-Kinases | 2 | 2015 | 890 | 0.050 |
Why?
|
Pongo | 1 | 2019 | 4 | 0.050 |
Why?
|
DNA Breaks | 1 | 2020 | 49 | 0.050 |
Why?
|
NIH 3T3 Cells | 2 | 2012 | 677 | 0.050 |
Why?
|
Heterozygote | 2 | 2020 | 2804 | 0.040 |
Why?
|
Cardiovascular Abnormalities | 1 | 2000 | 144 | 0.040 |
Why?
|
Carcinoma | 1 | 2011 | 2375 | 0.040 |
Why?
|
Hydrogen Peroxide | 1 | 2023 | 731 | 0.040 |
Why?
|
Inflammation | 1 | 1999 | 10638 | 0.040 |
Why?
|
Biochemical Phenomena | 1 | 2019 | 59 | 0.040 |
Why?
|
3' Untranslated Regions | 1 | 2021 | 513 | 0.040 |
Why?
|
Gene Silencing | 2 | 2017 | 1538 | 0.040 |
Why?
|
Enzyme Assays | 1 | 2020 | 111 | 0.040 |
Why?
|
Pan troglodytes | 1 | 2019 | 229 | 0.040 |
Why?
|
Aged, 80 and over | 7 | 2021 | 57776 | 0.040 |
Why?
|
Dyspepsia | 1 | 2000 | 115 | 0.040 |
Why?
|
Albuterol | 1 | 2000 | 208 | 0.040 |
Why?
|
Phosphorylation | 3 | 2019 | 8436 | 0.040 |
Why?
|
Glioblastoma | 2 | 2015 | 3481 | 0.040 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2021 | 575 | 0.040 |
Why?
|
Substrate Specificity | 2 | 2019 | 1801 | 0.040 |
Why?
|
Hep G2 Cells | 1 | 2020 | 393 | 0.040 |
Why?
|
Peptide Hydrolases | 1 | 2022 | 634 | 0.040 |
Why?
|
Jumonji Domain-Containing Histone Demethylases | 1 | 2019 | 182 | 0.040 |
Why?
|
Ethylnitrosourea | 1 | 2018 | 51 | 0.040 |
Why?
|
Oligonucleotide Array Sequence Analysis | 3 | 2014 | 3920 | 0.040 |
Why?
|
Medicare | 1 | 1996 | 6566 | 0.040 |
Why?
|
Amino Acid Motifs | 2 | 2012 | 936 | 0.040 |
Why?
|
Skin Neoplasms | 1 | 2018 | 5686 | 0.040 |
Why?
|
Mi-2 Nucleosome Remodeling and Deacetylase Complex | 1 | 2019 | 113 | 0.040 |
Why?
|
K562 Cells | 1 | 2020 | 634 | 0.040 |
Why?
|
Multigene Family | 2 | 2013 | 1102 | 0.040 |
Why?
|
Poisson Distribution | 1 | 2019 | 513 | 0.040 |
Why?
|
Cytotoxicity, Immunologic | 1 | 2022 | 1369 | 0.040 |
Why?
|
Cells, Cultured | 3 | 2021 | 19229 | 0.040 |
Why?
|
Binding Sites | 2 | 2021 | 6114 | 0.040 |
Why?
|
Receptors, Cell Surface | 2 | 2012 | 2866 | 0.040 |
Why?
|
Liver Neoplasms | 1 | 2013 | 4253 | 0.040 |
Why?
|
Epidural Space | 1 | 2018 | 124 | 0.040 |
Why?
|
RNA Interference | 2 | 2020 | 2889 | 0.040 |
Why?
|
Cytomegalovirus | 1 | 2022 | 732 | 0.040 |
Why?
|
Entropy | 1 | 2018 | 209 | 0.040 |
Why?
|
RNA Polymerase II | 1 | 2021 | 551 | 0.040 |
Why?
|
Allelic Imbalance | 1 | 2017 | 77 | 0.040 |
Why?
|
Protein Array Analysis | 1 | 2019 | 411 | 0.040 |
Why?
|
Cell Hypoxia | 1 | 2019 | 675 | 0.040 |
Why?
|
Histone Deacetylases | 1 | 2022 | 728 | 0.040 |
Why?
|
RNA, Messenger | 3 | 2018 | 13033 | 0.040 |
Why?
|
Helicobacter pylori | 1 | 2000 | 382 | 0.040 |
Why?
|
Louisiana | 1 | 1996 | 108 | 0.040 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 1 | 2020 | 697 | 0.040 |
Why?
|
Helicobacter Infections | 1 | 2000 | 386 | 0.040 |
Why?
|
Oxidative Phosphorylation | 1 | 2019 | 481 | 0.040 |
Why?
|
Time Factors | 4 | 2023 | 40075 | 0.040 |
Why?
|
MAP Kinase Signaling System | 1 | 2004 | 1526 | 0.040 |
Why?
|
PTEN Phosphohydrolase | 2 | 2013 | 1142 | 0.040 |
Why?
|
Histocompatibility Antigens Class II | 1 | 2021 | 1475 | 0.030 |
Why?
|
Circular Dichroism | 1 | 2016 | 354 | 0.030 |
Why?
|
HLA Antigens | 1 | 2022 | 1381 | 0.030 |
Why?
|
Molecular Structure | 1 | 2021 | 1899 | 0.030 |
Why?
|
Amino Acid Substitution | 1 | 2021 | 1791 | 0.030 |
Why?
|
Positron-Emission Tomography | 1 | 2012 | 6234 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 2 | 2018 | 6538 | 0.030 |
Why?
|
Cell Division | 1 | 2023 | 4568 | 0.030 |
Why?
|
Neoplasm Staging | 3 | 2015 | 11031 | 0.030 |
Why?
|
Encephalitis | 1 | 1999 | 423 | 0.030 |
Why?
|
Conserved Sequence | 2 | 2014 | 1202 | 0.030 |
Why?
|
Walking | 1 | 2023 | 1180 | 0.030 |
Why?
|
Disease Models, Animal | 3 | 2023 | 18029 | 0.030 |
Why?
|
Neoplasm Invasiveness | 2 | 2014 | 3616 | 0.030 |
Why?
|
Recombinant Proteins | 1 | 2005 | 6622 | 0.030 |
Why?
|
Sulfones | 1 | 2018 | 437 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2020 | 783 | 0.030 |
Why?
|
Coculture Techniques | 1 | 2019 | 1341 | 0.030 |
Why?
|
Bayes Theorem | 2 | 2014 | 2309 | 0.030 |
Why?
|
Epitopes | 1 | 2022 | 2571 | 0.030 |
Why?
|
Extracellular Signal-Regulated MAP Kinases | 1 | 2018 | 625 | 0.030 |
Why?
|
Neoplasm Recurrence, Local | 3 | 2020 | 9239 | 0.030 |
Why?
|
Vero Cells | 1 | 2016 | 485 | 0.030 |
Why?
|
Structure-Activity Relationship | 1 | 2021 | 3129 | 0.030 |
Why?
|
Hong Kong | 1 | 2015 | 148 | 0.030 |
Why?
|
Child, Preschool | 9 | 2020 | 41006 | 0.030 |
Why?
|
STAT3 Transcription Factor | 1 | 2019 | 873 | 0.030 |
Why?
|
Principal Component Analysis | 1 | 2018 | 940 | 0.030 |
Why?
|
Chromosomes | 1 | 2018 | 596 | 0.030 |
Why?
|
Gene Knock-In Techniques | 1 | 2016 | 418 | 0.030 |
Why?
|
Muscle, Skeletal | 1 | 2010 | 4931 | 0.030 |
Why?
|
Protein Conformation | 2 | 2014 | 4011 | 0.030 |
Why?
|
Selection, Genetic | 1 | 2019 | 914 | 0.030 |
Why?
|
Programming Languages | 1 | 2015 | 133 | 0.030 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2019 | 713 | 0.030 |
Why?
|
DNA, Viral | 1 | 2021 | 2225 | 0.030 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2019 | 1285 | 0.030 |
Why?
|
Genes, BRCA2 | 1 | 2017 | 618 | 0.030 |
Why?
|
Chromosomes, Human, Pair 19 | 1 | 2015 | 367 | 0.030 |
Why?
|
Primary Prevention | 1 | 1981 | 1167 | 0.030 |
Why?
|
Chromosomes, Human, Pair 3 | 1 | 2014 | 323 | 0.030 |
Why?
|
Oligonucleotides, Antisense | 1 | 2016 | 433 | 0.030 |
Why?
|
Adenomatous Polyposis Coli Protein | 1 | 2014 | 188 | 0.030 |
Why?
|
Autophagy | 1 | 2022 | 1300 | 0.030 |
Why?
|
Hand Strength | 1 | 2017 | 448 | 0.030 |
Why?
|
Stromal Cells | 1 | 2019 | 1355 | 0.030 |
Why?
|
Antibodies | 1 | 2022 | 2460 | 0.030 |
Why?
|
Human papillomavirus 18 | 1 | 2014 | 128 | 0.030 |
Why?
|
Patch-Clamp Techniques | 1 | 2016 | 964 | 0.030 |
Why?
|
Genes, BRCA1 | 1 | 2017 | 781 | 0.030 |
Why?
|
Oligonucleotides | 1 | 2016 | 572 | 0.030 |
Why?
|
Collagen | 1 | 2022 | 2689 | 0.030 |
Why?
|
Databases, Protein | 1 | 2015 | 383 | 0.030 |
Why?
|
Databases, Nucleic Acid | 1 | 2014 | 211 | 0.030 |
Why?
|
Deoxyribonuclease I | 1 | 2013 | 229 | 0.030 |
Why?
|
Catalytic Domain | 1 | 2015 | 698 | 0.030 |
Why?
|
Indoles | 1 | 2021 | 1839 | 0.030 |
Why?
|
Immunohistochemistry | 2 | 2014 | 11366 | 0.030 |
Why?
|
Introns | 1 | 2016 | 991 | 0.030 |
Why?
|
Child | 11 | 2020 | 77709 | 0.030 |
Why?
|
RNA Splice Sites | 1 | 2014 | 209 | 0.030 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2015 | 658 | 0.030 |
Why?
|
Pyrimidines | 2 | 2018 | 2942 | 0.030 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2013 | 318 | 0.030 |
Why?
|
Organ Culture Techniques | 1 | 2015 | 813 | 0.030 |
Why?
|
MAP Kinase Kinase Kinases | 1 | 2014 | 261 | 0.030 |
Why?
|
Task Performance and Analysis | 1 | 2017 | 780 | 0.030 |
Why?
|
Base Composition | 1 | 2012 | 293 | 0.030 |
Why?
|
MicroRNAs | 2 | 2019 | 3752 | 0.030 |
Why?
|
Brain | 2 | 2016 | 26385 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2013 | 353 | 0.030 |
Why?
|
Lipids | 1 | 2023 | 3305 | 0.030 |
Why?
|
F-Box Proteins | 1 | 2013 | 197 | 0.030 |
Why?
|
TCF Transcription Factors | 1 | 2012 | 140 | 0.030 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 1 | 2015 | 705 | 0.030 |
Why?
|
Postural Balance | 1 | 2017 | 620 | 0.030 |
Why?
|
Virus Integration | 1 | 2013 | 299 | 0.030 |
Why?
|
Republic of Korea | 1 | 2013 | 539 | 0.030 |
Why?
|
Comparative Genomic Hybridization | 1 | 2013 | 496 | 0.030 |
Why?
|
ROC Curve | 1 | 2019 | 3527 | 0.030 |
Why?
|
Calcium | 2 | 2004 | 5756 | 0.030 |
Why?
|
Protein Interaction Mapping | 1 | 2015 | 627 | 0.030 |
Why?
|
Marketing | 1 | 2013 | 212 | 0.020 |
Why?
|
Vietnam | 1 | 2012 | 408 | 0.020 |
Why?
|
3T3 Cells | 1 | 2013 | 1101 | 0.020 |
Why?
|
England | 2 | 1983 | 522 | 0.020 |
Why?
|
Mutagenesis, Insertional | 1 | 2014 | 655 | 0.020 |
Why?
|
Interneurons | 1 | 2016 | 577 | 0.020 |
Why?
|
Infant | 7 | 2020 | 35136 | 0.020 |
Why?
|
rac1 GTP-Binding Protein | 1 | 2012 | 237 | 0.020 |
Why?
|
Obesity | 1 | 2013 | 12745 | 0.020 |
Why?
|
Video Recording | 1 | 2016 | 949 | 0.020 |
Why?
|
Transfection | 1 | 2019 | 5892 | 0.020 |
Why?
|
Myeloid-Lymphoid Leukemia Protein | 1 | 2013 | 294 | 0.020 |
Why?
|
Alternative Splicing | 1 | 2016 | 1117 | 0.020 |
Why?
|
Injections | 1 | 1994 | 840 | 0.020 |
Why?
|
Dimerization | 1 | 2012 | 893 | 0.020 |
Why?
|
Mandible | 1 | 1995 | 740 | 0.020 |
Why?
|
Databases, Factual | 2 | 2018 | 7729 | 0.020 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 1723 | 0.020 |
Why?
|
Leukemia, Myeloid | 1 | 2014 | 707 | 0.020 |
Why?
|
Chromosomes, Human, Pair 11 | 1 | 2011 | 417 | 0.020 |
Why?
|
Zebrafish | 1 | 2022 | 2994 | 0.020 |
Why?
|
Prognosis | 3 | 2020 | 29063 | 0.020 |
Why?
|
DNA Transposable Elements | 1 | 2014 | 748 | 0.020 |
Why?
|
Ribonucleases | 1 | 2011 | 287 | 0.020 |
Why?
|
Oculomotor Muscles | 1 | 1994 | 371 | 0.020 |
Why?
|
Mexico | 1 | 2012 | 690 | 0.020 |
Why?
|
Core Binding Factor Alpha 2 Subunit | 1 | 2012 | 345 | 0.020 |
Why?
|
Adolescent | 9 | 2020 | 85781 | 0.020 |
Why?
|
Mitochondria | 1 | 2023 | 3520 | 0.020 |
Why?
|
Biological Evolution | 1 | 2015 | 1076 | 0.020 |
Why?
|
Retroviridae | 1 | 2012 | 914 | 0.020 |
Why?
|
Temperature | 1 | 2016 | 2206 | 0.020 |
Why?
|
Eye | 1 | 1994 | 729 | 0.020 |
Why?
|
DEAD-box RNA Helicases | 1 | 2012 | 375 | 0.020 |
Why?
|
RNA, Ribosomal, 5S | 1 | 2009 | 11 | 0.020 |
Why?
|
Epigenomics | 1 | 2015 | 903 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2020 | 2183 | 0.020 |
Why?
|
Gene Fusion | 1 | 2012 | 371 | 0.020 |
Why?
|
Basic Helix-Loop-Helix Leucine Zipper Transcription Factors | 1 | 2011 | 315 | 0.020 |
Why?
|
Disease Progression | 2 | 2016 | 13284 | 0.020 |
Why?
|
Exercise Test | 1 | 2017 | 2074 | 0.020 |
Why?
|
Receptors, Estrogen | 1 | 2017 | 2187 | 0.020 |
Why?
|
Smoking | 3 | 2013 | 8987 | 0.020 |
Why?
|
Government Regulation | 1 | 2013 | 522 | 0.020 |
Why?
|
Protein Multimerization | 1 | 2014 | 970 | 0.020 |
Why?
|
Immunoblotting | 1 | 2012 | 1682 | 0.020 |
Why?
|
Biopsy | 1 | 2021 | 6756 | 0.020 |
Why?
|
Gene Library | 1 | 2011 | 1074 | 0.020 |
Why?
|
Phylogeny | 1 | 2016 | 2803 | 0.020 |
Why?
|
RNA, Small Interfering | 1 | 2018 | 3505 | 0.020 |
Why?
|
Mice, Inbred C57BL | 2 | 2020 | 21827 | 0.020 |
Why?
|
Blood Pressure Determination | 1 | 1992 | 634 | 0.020 |
Why?
|
src-Family Kinases | 1 | 2011 | 551 | 0.020 |
Why?
|
bcl-X Protein | 1 | 2010 | 411 | 0.020 |
Why?
|
Multiprotein Complexes | 1 | 2014 | 1119 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3588 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2014 | 2886 | 0.020 |
Why?
|
Tumor Necrosis Factor-alpha | 1 | 2020 | 4420 | 0.020 |
Why?
|
Wnt Proteins | 1 | 2012 | 721 | 0.020 |
Why?
|
Commerce | 1 | 2013 | 592 | 0.020 |
Why?
|
Methylation | 1 | 2011 | 1106 | 0.020 |
Why?
|
Antigens, Neoplasm | 1 | 2016 | 1988 | 0.020 |
Why?
|
Behavior, Animal | 1 | 2016 | 1881 | 0.020 |
Why?
|
Immunotherapy | 1 | 2023 | 4445 | 0.020 |
Why?
|
DNA Primers | 1 | 2012 | 2892 | 0.020 |
Why?
|
Proto-Oncogenes | 1 | 2008 | 321 | 0.020 |
Why?
|
Prostheses and Implants | 1 | 1995 | 1387 | 0.020 |
Why?
|
Sequence Homology, Nucleic Acid | 1 | 2009 | 1085 | 0.020 |
Why?
|
Genetic Markers | 1 | 2014 | 2634 | 0.020 |
Why?
|
Open Reading Frames | 1 | 2011 | 810 | 0.020 |
Why?
|
HeLa Cells | 1 | 2014 | 3128 | 0.020 |
Why?
|
Hedgehog Proteins | 1 | 2012 | 783 | 0.020 |
Why?
|
Activities of Daily Living | 1 | 2017 | 2418 | 0.020 |
Why?
|
Attitude to Health | 1 | 1996 | 2052 | 0.020 |
Why?
|
Intestine, Small | 1 | 2013 | 1241 | 0.020 |
Why?
|
Factor Analysis, Statistical | 1 | 2010 | 977 | 0.020 |
Why?
|
Cytokines | 1 | 2022 | 7322 | 0.020 |
Why?
|
Chromosome Deletion | 1 | 2011 | 1401 | 0.020 |
Why?
|
DNA Helicases | 1 | 2012 | 859 | 0.020 |
Why?
|
Benchmarking | 1 | 2013 | 1042 | 0.020 |
Why?
|
Up-Regulation | 1 | 2016 | 4217 | 0.020 |
Why?
|
Sequence Deletion | 1 | 2011 | 1526 | 0.020 |
Why?
|
Anesthetics, Local | 1 | 1994 | 985 | 0.020 |
Why?
|
Muscle Fibers, Skeletal | 1 | 2010 | 555 | 0.020 |
Why?
|
Gene Knockdown Techniques | 1 | 2011 | 1655 | 0.020 |
Why?
|
Hypertension, Renal | 1 | 1967 | 177 | 0.020 |
Why?
|
Exercise | 1 | 2023 | 5615 | 0.020 |
Why?
|
RNA, Transfer | 1 | 2009 | 316 | 0.020 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 4751 | 0.020 |
Why?
|
Tandem Mass Spectrometry | 1 | 2012 | 1157 | 0.020 |
Why?
|
Tumor Burden | 1 | 2012 | 1915 | 0.020 |
Why?
|
Blotting, Western | 1 | 2014 | 5179 | 0.020 |
Why?
|
Treatment Failure | 1 | 2012 | 2618 | 0.020 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10180 | 0.020 |
Why?
|
Pectoralis Muscles | 1 | 1966 | 82 | 0.020 |
Why?
|
Kidney | 1 | 2001 | 7186 | 0.020 |
Why?
|
Radiotherapy Dosage | 1 | 2012 | 2879 | 0.020 |
Why?
|
Carbon | 1 | 2009 | 687 | 0.020 |
Why?
|
Blood Coagulation | 1 | 2011 | 1127 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
Quinazolines | 1 | 2011 | 1356 | 0.020 |
Why?
|
Ribs | 1 | 1966 | 252 | 0.020 |
Why?
|
Young Adult | 2 | 2021 | 56430 | 0.020 |
Why?
|
Recurrence | 1 | 2016 | 8340 | 0.020 |
Why?
|
Phorbol Esters | 1 | 2004 | 111 | 0.010 |
Why?
|
Lymph Nodes | 1 | 2015 | 3474 | 0.010 |
Why?
|
Thiazoles | 1 | 2011 | 1483 | 0.010 |
Why?
|
Rubella | 1 | 1983 | 48 | 0.010 |
Why?
|
Neoplasm Metastasis | 1 | 2014 | 4851 | 0.010 |
Why?
|
Hippocampus | 1 | 2016 | 3675 | 0.010 |
Why?
|
Mice, Transgenic | 1 | 2016 | 9734 | 0.010 |
Why?
|
Protein Biosynthesis | 1 | 2011 | 2126 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-akt | 1 | 2012 | 2503 | 0.010 |
Why?
|
Gene Deletion | 1 | 2011 | 2751 | 0.010 |
Why?
|
Neoadjuvant Therapy | 1 | 2014 | 2728 | 0.010 |
Why?
|
Cell Differentiation | 2 | 2011 | 11483 | 0.010 |
Why?
|
Acute Disease | 1 | 2014 | 7149 | 0.010 |
Why?
|
Proto-Oncogene Proteins c-bcl-2 | 1 | 2010 | 1434 | 0.010 |
Why?
|
Internet | 1 | 2015 | 3064 | 0.010 |
Why?
|
Polymerase Chain Reaction | 1 | 2012 | 6171 | 0.010 |
Why?
|
NF-kappa B | 1 | 2011 | 2499 | 0.010 |
Why?
|
Disease-Free Survival | 1 | 2012 | 6895 | 0.010 |
Why?
|
Virulence Factors, Bordetella | 1 | 2001 | 156 | 0.010 |
Why?
|
Homeodomain Proteins | 1 | 2011 | 2421 | 0.010 |
Why?
|
Thoracic Vertebrae | 1 | 1966 | 608 | 0.010 |
Why?
|
Pertussis Toxin | 1 | 2001 | 178 | 0.010 |
Why?
|
Prospective Studies | 2 | 2018 | 53288 | 0.010 |
Why?
|
Absorption | 1 | 2001 | 248 | 0.010 |
Why?
|
Ambulatory Care | 1 | 1992 | 2708 | 0.010 |
Why?
|
Massachusetts | 1 | 2014 | 8663 | 0.010 |
Why?
|
Asthma | 1 | 2000 | 6011 | 0.010 |
Why?
|
Templates, Genetic | 1 | 2001 | 211 | 0.010 |
Why?
|
Repressor Proteins | 1 | 2012 | 3023 | 0.010 |
Why?
|
Congenital Abnormalities | 1 | 1966 | 707 | 0.010 |
Why?
|
Electroencephalography | 1 | 2016 | 6150 | 0.010 |
Why?
|
Vaginal Smears | 1 | 1983 | 511 | 0.010 |
Why?
|
Heart Murmurs | 1 | 2000 | 94 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
Type C Phospholipases | 1 | 2001 | 292 | 0.010 |
Why?
|
Treatment Outcome | 2 | 2019 | 63114 | 0.010 |
Why?
|
Adaptor Proteins, Signal Transducing | 1 | 2011 | 2916 | 0.010 |
Why?
|
Powders | 1 | 2000 | 80 | 0.010 |
Why?
|
Directed Molecular Evolution | 1 | 2001 | 160 | 0.010 |
Why?
|
Cell Movement | 1 | 2012 | 5217 | 0.010 |
Why?
|
Noonan Syndrome | 1 | 2000 | 122 | 0.010 |
Why?
|
Therapeutic Equivalency | 1 | 2000 | 141 | 0.010 |
Why?
|
Homeostasis | 1 | 2011 | 3340 | 0.010 |
Why?
|
Cyclic AMP | 1 | 2004 | 1472 | 0.010 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2001 | 315 | 0.010 |
Why?
|
Pulmonary Valve Stenosis | 1 | 2000 | 183 | 0.010 |
Why?
|
Cell Survival | 1 | 2010 | 5882 | 0.010 |
Why?
|
B-Lymphocytes | 1 | 2013 | 4665 | 0.010 |
Why?
|
Fibroblasts | 1 | 2010 | 4161 | 0.010 |
Why?
|
Nebulizers and Vaporizers | 1 | 2000 | 139 | 0.010 |
Why?
|
Mitral Valve Prolapse | 1 | 2000 | 231 | 0.010 |
Why?
|
Aortic Coarctation | 1 | 2000 | 281 | 0.010 |
Why?
|
Survival Rate | 1 | 2012 | 12788 | 0.010 |
Why?
|
Electrophysiology | 1 | 2001 | 1308 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2020 | 77449 | 0.010 |
Why?
|
Sensitivity and Specificity | 1 | 2013 | 14722 | 0.010 |
Why?
|
Carrier Proteins | 1 | 2011 | 5021 | 0.010 |
Why?
|
Aerosols | 1 | 2000 | 625 | 0.010 |
Why?
|
Risk Factors | 2 | 2014 | 72290 | 0.010 |
Why?
|
Prevalence | 1 | 2014 | 15226 | 0.010 |
Why?
|
United States | 2 | 2013 | 69872 | 0.010 |
Why?
|
Electrocardiography, Ambulatory | 1 | 2000 | 585 | 0.010 |
Why?
|
Spirometry | 1 | 2000 | 864 | 0.010 |
Why?
|
Pregnancy | 1 | 2018 | 29144 | 0.010 |
Why?
|
Aging | 1 | 2015 | 8664 | 0.010 |
Why?
|
Predictive Value of Tests | 1 | 2012 | 15076 | 0.010 |
Why?
|
GTP-Binding Proteins | 1 | 2001 | 970 | 0.010 |
Why?
|
Bronchodilator Agents | 1 | 2000 | 502 | 0.010 |
Why?
|
Methylmethacrylate | 1 | 1995 | 44 | 0.010 |
Why?
|
Methylmethacrylates | 1 | 1995 | 72 | 0.010 |
Why?
|
Quality of Life | 1 | 2017 | 12804 | 0.010 |
Why?
|
Membrane Proteins | 1 | 2012 | 7880 | 0.010 |
Why?
|
Forced Expiratory Volume | 1 | 2000 | 1743 | 0.010 |
Why?
|
Porosity | 1 | 1995 | 362 | 0.010 |
Why?
|
Silicones | 1 | 1995 | 250 | 0.010 |
Why?
|
Syndrome | 1 | 2000 | 3251 | 0.010 |
Why?
|
Polyethylenes | 1 | 1995 | 285 | 0.010 |
Why?
|
Blood Pressure Monitors | 1 | 1992 | 33 | 0.010 |
Why?
|
Risk Assessment | 1 | 2014 | 23338 | 0.010 |
Why?
|
Quality of Health Care | 2 | 1985 | 4371 | 0.010 |
Why?
|
Bone Resorption | 1 | 1995 | 723 | 0.010 |
Why?
|
Cell Membrane | 1 | 2001 | 3748 | 0.010 |
Why?
|
Rabbits | 1 | 1995 | 4894 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2012 | 20129 | 0.010 |
Why?
|
Heart Rate | 1 | 2000 | 4091 | 0.010 |
Why?
|
Rats | 1 | 2004 | 24260 | 0.000 |
Why?
|
Radioisotope Renography | 1 | 1967 | 62 | 0.000 |
Why?
|
Electrocardiography | 1 | 2000 | 6442 | 0.000 |
Why?
|
Hand Deformities, Acquired | 1 | 1966 | 36 | 0.000 |
Why?
|
Double-Blind Method | 1 | 2000 | 12026 | 0.000 |
Why?
|
Urography | 1 | 1967 | 313 | 0.000 |
Why?
|
Aortography | 1 | 1967 | 437 | 0.000 |
Why?
|
Chronic Disease | 1 | 2000 | 9146 | 0.000 |
Why?
|
Kidney Function Tests | 1 | 1967 | 684 | 0.000 |
Why?
|
Wrist | 1 | 1966 | 224 | 0.000 |
Why?
|
Potassium | 1 | 1967 | 1336 | 0.000 |
Why?
|
Angiography | 1 | 1967 | 1639 | 0.000 |
Why?
|
Radiography, Thoracic | 1 | 1966 | 1265 | 0.000 |
Why?
|
Infant, Newborn | 2 | 1967 | 25625 | 0.000 |
Why?
|
Age Factors | 1 | 1985 | 18370 | 0.000 |
Why?
|
Hypertension | 1 | 1985 | 8480 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1967 | 39050 | 0.000 |
Why?
|